as well as a variety of preclinical research and development programs. Emisphere is carrying out these programs both in collaboration with pharmaceutical and biotechnology companies...

ChemistMarch 2011 520. KB Poor permeability of pharmaceutical actives prevents many drugs from reaching the market. David Gschneidner, Emisphere Technologies, highlights a technology... 688 KB The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market... Read more The New York Times - A Push for Adding B12, Though.... Novinski, a veteran in the pharmaceutical industry, has been president and CEO at Emisphere Technologies in Cedar Knolls since May 2007... Read more The Star Ledger - Untapped...